72. Rugo, H.S., et al., Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Rece ptor 2 -Negative Advanced Breast Cancer. Clin Cancer Res, 2018. 24(12): p. 2804-2811. 73. Fakhry, C., et al., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinic al trial. J Natl Cancer Inst, 2008. 100(4): p. 261-9.